Multidisciplinary management of lung cancer.
作者： Alexander Spira , David S. Ettinger
DOI: 10.1056/NEJMRA035536
关键词:
摘要: Despite years of research, the five-year survival rate among patients with lung cancer is a mere 14 percent. Lung divided into two major types — non–small-cell and more aggressive small-cell cancer. This review considers treatment each type in framework multidisciplinary management recent clinical trials.
elsevier.com
sci-hub.se 参考文章(112)
G Fountzilas, D Skarlos, E Samantas, P A Kosmidis, F Apostolopoulou, N Pavlidis, Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials. Seminars in Oncology. ,vol. 21, pp. 23- 30 ,(1994)
R Grilli, M Leoni, S Scoccia, C Vergari, U Borghini, G Luporini, E Soresi, M Botturi, M Clerici, R Zucali, A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Seminars in Oncology. ,vol. 15, pp. 20- 25 ,(1988)
Eric J. Seifter, Daniel C. Ihde, Therapy of small cell lung cancer: a perspective on two decades of clinical research. Seminars in Oncology. ,vol. 15, pp. 278- 299 ,(1988) , 10.5555/URI:PII:0093775488900498
RJ Stephens, , DJ Girling, NM Bleehen, K Moghissi, HMA Yosef, D Machin, The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. British Journal of Cancer. ,vol. 74, pp. 632- 639 ,(1996) , 10.1038/BJC.1996.413
W. Whitson, R. Komaki, J. D. Cox, Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer treatment reports. ,vol. 65, pp. 811- 814 ,(1981)
M. H. Cullen, L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, R. M. Rudd, S. G. Spiro, J. E. Cook, C. Trask, E. Bessell, C. K. Connolly, J. Tobias, R. L. Souhami, Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life Journal of Clinical Oncology. ,vol. 17, pp. 3188- 3194 ,(1999) , 10.1200/JCO.1999.17.10.3188
H Choy, W Akerley, H Safran, S Graziano, C Chung, T Williams, B Cole, T Kennedy, Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 16, pp. 3316- 3322 ,(1998) , 10.1200/JCO.1998.16.10.3316
Jean Klastersky, Jean-Paul Sculier, Hendrik Lacroix, Gérard Dabouis, Gérard Bureau, P Libert, Michel Richez, Pol Ravez, Guy Vandermoten, Jacques Thiriaux, None, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. Journal of Clinical Oncology. ,vol. 8, pp. 1556- 1562 ,(1990) , 10.1200/JCO.1990.8.9.1556
A J Wozniak, J J Crowley, S P Balcerzak, G R Weiss, C H Spiridonidis, L H Baker, K S Albain, K Kelly, S A Taylor, D R Gandara, R B Livingston, Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study Journal of Clinical Oncology. ,vol. 16, pp. 2459- 2465 ,(1998) , 10.1200/JCO.1998.16.7.2459
Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354